Medical Devices

Lupin has launched a generic version of the blockbuster diabetes drug Farxiga, signaling lower costs for patients and a major shake-up in the SGLT2 market.

Parnell’s nixiFLOR, the first generic of Resflor Gold®, offers a cost-effective new weapon for ranchers battling Bovine Respiratory Disease.

A startling new study reveals a sharp rise in diagnosed anxiety, highlighting a growing public health crisis and an urgent need for treatment innovation.

Telehealth firm Direct Meds offers cheap GLP-1 drugs, but an FDA warning for "false claims" and the end of drug shortages cast a long shadow on its model.

Investors sue Corcept Therapeutics, claiming the company hid FDA warnings about its key drug, relacorilant, before a 50% stock price collapse.

The diagnostics firm has 180 days to boost its market value after a Nasdaq warning, placing immense pressure on its turnaround and high-stakes biosensor plans.

With stockholder approval, Abbott's acquisition of Exact Sciences is set to reshape the cancer diagnostics landscape and accelerate early detection.

Amid soaring demand, Cleanroom Film & Bags adds a high-speed production line, reinforcing the supply chains for vital medical and semiconductor industries.

A Quebec partnership has completed the first building with carbon-negative, insulated blocks, a breakthrough aiming to decarbonize construction from the ground up.

A $350,000 donation from prominent philanthropists will equip TGH's new Taneja Tower with a state-of-the-art iMRI, transforming brain surgery.

Guerbet's Elucirem™ gains FDA approval for patients aged 0-2, halving gadolinium exposure in the most vulnerable without sacrificing diagnostic quality.

New England Biolabs is launching next-gen sample prep tools, targeting long-read sequencing, RNA bias, and clinical epigenetics to accelerate discovery.

CU Boulder's new field from Brock USA promises fewer injuries and more concerts, but is it the perfect fix? A deep dive into the tech and strategy.

With a 180% surge in orders and record profits, Theon leverages strategic acquisitions to move beyond night vision and lead the defense optoelectronics market.

A lawsuit claims a specialized pediatric daycare failed to protect a vulnerable child, leading to unexplained injuries and a state investigation.

With a key gas deal signed, construction begins on the world's largest ultra-low carbon methanol plant in Sinaloa, a $3.3B bet on sustainable fuels.

LEX Diagnostics' newly FDA-cleared VELO system delivers lab-quality PCR results for flu & COVID in under 10 minutes, set to revolutionize point-of-care testing.

Dr. Batra's launches XODerma, a high-tech exosome skin therapy in Dubai, blending homeopathy with cellular science. But does the hype outpace regulation?

Tokyo-based materials giant DIC is investing $62M in Physical AI, partnering with a Swiss VC to bridge the gap between the digital and physical worlds.

Nemours Foundation adds Advocate Health's Dr. Betty Chu to its board, a strategic move to leverage her expertise in quality, equity, and large-scale operations.